Medtronic (NYSE:MDT) has received FDA approval for its Affera Mapping and Ablation System with Sphere-9 Catheter. The system is an all-in-one, high-density mapping and pulsed field and radiofrequency ablation catheter for treatment of persistent atrial fibrillation, or AFib, and for radiofrequency ablation of